Avantis U.S. Small Cap Value ETF (AVUV)
ETF · Equity · Avantis · Data as of 2026-10-22
Bottom line
AVUV is an Avantis fund that picks US stocks by a rule such as momentum, quality or low volatility, for 0.25% a year. Over the past year its price rose 23.6%, 9.8 points ahead of the S&P 500. It pays about 1.2% a year, every quarter. Past returns are not a guarantee of future results.
Fund facts
Fee: 0.25% a year
Assets: $31.2B
Holdings: 794
Payouts, past 12 months: 1.24%
Past year
23.58% price · 25.22% with payouts
About the fund
This ETF allocates capital across a broad spectrum of small-capitalization companies within the U.S. market. Its core strategy seeks to enhance expected returns by identifying firms with robust profitability that are trading at what Avantis considers attractive, low valuations. While incorporating the hallmarks of passive indexing – such as broad diversification, low portfolio turnover, and transparent exposures – the fund also aims to add value through active investment decisions informed by real-time market pricing. It benefits from an efficient portfolio management and trading approach, meticulously designed to boost returns while simultaneously reducing unnecessary costs and potential risks for investors. Ultimately, this ETF is built to seamlessly complement an investor's overall asset allocation.
Related funds
- iShares MSCI USA Quality Factor ETF (QUAL)
- iShares MSCI USA Min Vol Factor ETF (USMV)
- Pacer US Cash Cows 100 ETF (COWZ)
- Invesco S&P 500 Quality ETF (SPHQ)
- iShares MSCI USA Momentum Factor ETF (MTUM)
- iShares MSCI USA Value Factor ETF (VLUE)
- Invesco S&P 500 Low Volatility ETF (SPLV)
- Vanguard Morningstar Total Stock Market ETF (VTI)
一句话结论
AVUV 是 Avantis 旗下按动量、质量或低波动等规则挑选美股的基金，年费率 0.25%。过去一年价格上涨 23.6%，领先标普 500 9.8 个百分点。每年派息约 1.2%，按季派发。过往表现并不能保证未来的结果。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.